GsMTx4
CAS No. 1209500-46-8
GsMTx4( —— )
Catalog No. M30369 CAS No. 1209500-46-8
GsMTx-4, mechanosensitive and stretch-activated ion channel inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1044 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameGsMTx4
-
NoteResearch use only, not for human use.
-
Brief DescriptionGsMTx-4, mechanosensitive and stretch-activated ion channel inhibitor.
-
DescriptionGsMTx-4, mechanosensitive and stretch-activated ion channel inhibitor.
-
In VitroGsMTx4 (5 μM) reduces Piezo1-mediated charge transfer to 38% of its initial levels in HEK293 cells transfected with Piezo1 cDNA.GsMTx4 (5 μM) blocks cation-selective stretch-activated channels in astrocytes, cardiac cells, and smooth and skeletal muscle cells.GsMTx4 (2.5 μM, 16 h) significantly diminishes both the leptin-induced AMPK and MLC-2 phosphorylation in breast epithelial cells (MCF10A).GsMTx4 (500 nM, 48 h) attenuates demyelination induced by the cytotoxic lipid and psychosine (organotypic cerebellar slices). Western Blot Analysis Cell Line:MCF10A cells Concentration:2.5 μM Incubation Time:16 h Result:Diminished both the leptin-induced AMPK and MLC-2 phosphorylation.
-
In VivoGsMTx4 (stereotactic injection, 3 μM of 1 μL, a single dose) is neuroprotective and inhibits lysophosphatidylcholine-induced astrocyte toxicity and demyelination in the cerebral cortex.GsMTx-4 (intraperitoneal injection, 270 μg/kg for a single dose) reduces mechanical allodynia induced by inflammation and by sciatic nerve injury in Von Frey test. Animal Model:Male C57BL/6 mice (toxin-induced focal demyelination of cortical brain tissue)Dosage:3 μM for 1 μL, a single dose.Administration:Stereotactic injection in the left and right cerebral hemispheres (sacrificed 4 days post-injection)Result:Prevented the enhanced increase in microglial reactivity and microglial cell numbers induced by lysophosphatidylcholine (LPC).Prevented LPC-mediated astrocyte toxicity by attenuating the decrease in GFAP+ cells and GFAP fluorescence intensity.Animal Model:Sciatic nerve injury model of male Sprague-Dawley rats Dosage:270 μg/kg, a single dose Administration:Intraperitoneal injection Result:Reduced inflammation-evoked mechanical allodynia.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorMSCs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1209500-46-8
-
Formula Weight4101.89
-
Molecular FormulaC185H279N49O45S6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (12.21 mM)
-
SMILES——
-
Chemical NameSequence:Gly-Cys-Leu-Glu-Phe-Trp-Trp-Lys-Cys-Asn-Pro-Asn-Asp-Asp-Lys-Cys-Cys-Arg-Pro-Lys-Leu-Lys-Cys-Ser-Lys-Leu-Phe-Lys-Leu-Cys-Asn-Phe-Ser-Phe
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Gnanasambandam R, et al. GsMTx4: Mechanism of Inhibiting Mechanosensitive Ion Channels. Biophys J. 2017 Jan 10;112(1):31-45.
molnova catalog
related products
-
K 0859
BGG463 can inhibit c-ABL-T334I, BCR-ABL and BCR-ABL-T315I variants with a 50% inhibitory concentration (IC50) of 0.25 μM, 0.09 μM and 0.590 μM, respectively.
-
A 425619
A 425619 is a potent TRPV1 antagonistsystemic administration of the TRPV1 antagonist, A-425619, reversed the decrease in digging behavior induced by CFA injection, further confirming the role of TRPV1, expressed by knee neurons, in acute inflammatory joint pain.
-
2'-acetylacteoside
2'-Acetylacteoside has antioxidative activity. It can significantly attenuate glutamate-induced neurotoxicity at concentrations ranging from 0.1 to 10 μM. 2'-Acetylacteoside.
Cart
sales@molnova.com